Prestige Consumer Healthcare (PBH) Total Current Liabilities (2011 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Total Current Liabilities came in at $139.6 million in Q4 2025, up 36.09% year-on-year from $102.5 million in Q4 2024, and up 3.68% quarter-over-quarter from $134.6 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Total Current Liabilities (2011 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $139.6 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 36.09% year-over-year to $139.6 million in Q4 2025; TTM through Dec 2025 was $139.6 million, a 36.09% increase from a year earlier, with the FY2025 full-year figure at $106.6 million, down 8.91% from the prior year.
  • Total Current Liabilities rose to $139.6 million in Q4 2025 per PBH's latest filing, from $134.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $160.7 million in Q1 2023 and bottomed at $102.5 million in Q4 2024.
  • The 5-year median for Total Current Liabilities is $132.2 million (2023), against an average of $131.9 million.
  • Across the five-year window, Total Current Liabilities declined 27.17% in 2024 and surged 36.09% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $135.1 million in 2021, then increased by 18.54% to $160.2 million in 2022, then retreated by 20.44% to $127.4 million in 2023, then fell by 19.53% to $102.5 million in 2024, then jumped by 36.09% to $139.6 million in 2025.
  • Per Business Quant, the three latest PBH Total Current Liabilities figures stand at $139.6 million (Q4 2025), $134.6 million (Q3 2025), and $109.7 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn 139.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 139.56 Mn
Sep 30, 2025 134.60 Mn
Jun 30, 2025 109.67 Mn
Mar 31, 2025 106.62 Mn
Dec 31, 2024 102.55 Mn
Sep 30, 2024 106.91 Mn
Jun 30, 2024 114.12 Mn
Mar 31, 2024 117.05 Mn
Dec 31, 2023 127.44 Mn
Sep 30, 2023 129.70 Mn
Jun 30, 2023 147.27 Mn
Mar 31, 2023 160.72 Mn
Dec 31, 2022 160.18 Mn
Sep 30, 2022 152.31 Mn
Jun 30, 2022 155.35 Mn
Mar 31, 2022 143.42 Mn
Dec 31, 2021 135.13 Mn
Sep 30, 2021 148.94 Mn
Jun 30, 2021 125.05 Mn
Mar 31, 2021 122.14 Mn